Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures. At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside. Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve. For more information, please visit www.ovidrx.com. Review our community guidelines: http://www.ovidrx.com/community-guidelines/
View Top Employees from Ovid TherapeuticsWebsite | http://www.ovidrx.com |
Ticker | OVID |
Revenue | $6 million |
Employees | 66 (66 on RocketReach) |
Founded | 2014 |
Address | 441 9th Avenue, New York, New York 10001, US |
Phone | (646) 661-7661 |
Technologies |
JavaScript,
HTML,
PHP
+69 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering |
Web Rank | 5 Million |
Keywords | Ovid Therapeutics, Jeremy Levin, Ovid Therapeutics Inc, Matt During, Ovid Investor Relations |
Competitors | Inozyme Pharma, Leap Therapeutics, Magenta Therapeutics, Orphazyme A/S, Visterra Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Ovid Therapeutics employee's phone or email?
The Ovid Therapeutics annual revenue was $6 million in 2024.
Robert Morales is the Senior Vice President Accounting and Finance of Ovid Therapeutics.
66 people are employed at Ovid Therapeutics.
Ovid Therapeutics is based in New York, New York.
The NAICS codes for Ovid Therapeutics are [32541, 3254, 325, 32].
The SIC codes for Ovid Therapeutics are [28, 283].